IP Library Granted Patent US 11,969,239
Granted Patent B2
US 11,969,239 · App. 16/743,418 · Granted Apr 30, 2024

Tumor tissue characterization using multi-parametric magnetic resonance imaging

Inventors: Bin Lou (Princeton, NJ); Benjamin L. Odry (West New York, NJ)
Assignee: Siemens Healthineers AG
A61B5/055G01R33/46G01R33/50G01R33/56341G06T7/0012G01R33/34084
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,969,239
App. No.
16/743,418
Granted
Apr 30, 2024
Kind
B2
Abstract

Brain tumor or other tissue classification and/or segmentation is provided based on from multi-parametric MRI. MRI spectroscopy, such as in combination with structural and/or diffusion MRI measurements, are used to classify. A machine-learned model or classifier distinguishes between the types of tissue in response to input of the multi-parametric MRI. To deal with limited training data for tumors, a patch-based system may be used. To better assist physicians in interpreting results, a confidence map may be generated using the machine-learned classifier.

Claims (18)

1. A method for characterizing tumor tissue from multi-parametric imaging by a magnetic resonance (MR) scanner, the method comprising:

scanning a patient by the MR scanner, the scanning including structural, diffusion, and spectroscopy measurements of the patient;

classifying the tumor tissue of the patient between two or more classes of tumor type, the classifying by a machine-learned neural network in response to input of the structural, diffusion, and spectroscopy measurements;

generating a confidence map comprising confidence values for each voxel that indicate a consistency of the machine-learned neural network's classification predictions over different network configurations; and

displaying an image of the tumor tissue segmented based on the two or more classes and the confidence map.

2. The method of claim 1 wherein scanning comprises scanning with the structural measurements including two or more of T1, T2, FLAIR, and T1 Post-Contrast measurements.

3. The method of claim 1 wherein scanning comprises scanning with the diffusion measurements including two or more of diffusion tensor imaging (DTI) axial diffusivity, DTI fractional anisotropy, DTI mean diffusivity, and diffusion weighted imaging (DWI) B0 measurements.

4. The method of claim 1 wherein scanning comprises scanning with the spectroscopy measurements including two or more of N-acetyl aspartate, creatine, lactate, water, gix, inositol, and choline measurements.

5. The method of claim 1 wherein the machine-learned neural network comprises a fully connected neural network.

6. The method of claim 1 wherein classifying comprises classifying by application of the machine-learned neural network patch-by-patch for different locations from the measurements.

7. The method of claim 1 wherein classifying comprises classifying as enhanced, edema, necrosis, and cavity tumor types.

8. The method of claim 1 wherein classifying comprises classifying between the two or more classes of tumor type and a class of normal tissue.

9. The method of claim 1 wherein classifying comprises classifying by the machine-learned neural network in response to input of the structural, diffusion, and spectroscopy measurements and a normal tissue mask.

10. The method of claim 1 further comprising co-registering the structural, diffusion, and spectroscopy measurements of the patient prior to the input to the machine-learned neural network.

11. The method of claim 1 further comprising locating the tumor tissue, wherein classifying comprises classifying the tumor tissue and tissue adjacent the tumor tissue without classifying tissue located a predetermined number of patches from the tissue adjacent the tumor tissue.

12. The method of claim 1 wherein scanning comprises scanning a brain of the patient, and wherein classifying comprises classifying the tumor tissue as brain tumor tissue.

13. The method of claim 1 wherein the machine-learned neural network was trained on training data of patches using weighted sampling of normal tissue related to tumor tissue.

14. The method of claim 1 , wherein for the different network configurations half of the nodes in a hidden layer and their corresponding connections to other nodes are randomly removed from the machine-learned neural network.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2023
From: SIEMENS HEALTHCARE GMBH
To: SIEMENS HEALTHINEERS AG
Reel/Frame 066267/0346 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2020
From: SIEMENS MEDICAL SOLUTIONS USA, INC.
To: SIEMENS HEALTHCARE GMBH
Reel/Frame 051828/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2020
From: LOU, BIN; ODRY, BENJAMIN L.
To: SIEMENS MEDICAL SOLUTIONS USA, INC.
Reel/Frame 051653/0940 →
Continuity (2)
Provisional Application 62812385 · Mar 1, 2019
Related Publication 20200275857A1 · Sep 3, 2020